martes, 27 de diciembre de 2022

Direct oral anticoagulants more effective and cost-effective for treating cancer-associated thrombosis

Direct oral anticoagulants more effective and cost-effective for treating cancer-associated thrombosis

No hay comentarios:

Publicar un comentario